BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1313445)

  • 1. Intravascular filarial parasites inhibit platelet aggregation. Role of parasite-derived prostanoids.
    Liu LX; Weller PF
    J Clin Invest; 1992 Apr; 89(4):1113-20. PubMed ID: 1313445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the activation of Hageman factor (factor XII) and of platelet aggregation by extracts of Brugia malayi microfilariae.
    Foster CB; Flanigan TP; Kazura JW; Dumenco LL; Ratnoff OD
    J Lab Clin Med; 1991 May; 117(5):344-52. PubMed ID: 1902251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids.
    Liu LX; Serhan CN; Weller PF
    J Exp Med; 1990 Sep; 172(3):993-6. PubMed ID: 2117642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diethylcarbamazine inhibits endothelial and microfilarial prostanoid metabolism in vitro.
    Kanesa-thasan N; Douglas JG; Kazura JW
    Mol Biochem Parasitol; 1991 Nov; 49(1):11-9. PubMed ID: 1775151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of immunosuppressive proteins of Brugia malayi microfilariae.
    Wadee AA; Vickery AC; Piessens WF
    Acta Trop; 1987 Sep; 44(3):343-52. PubMed ID: 2892371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protection against Brugia malayi infection in jirds by microfilarial antigens.
    Kazura JW; Cicirello H; McCall JW
    J Immunol; 1986 Feb; 136(4):1422-6. PubMed ID: 3944460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
    Schafer AI; Adelman B
    J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of arachidonic acid by microfilariae of Brugia malayi.
    Longworth DL; Foster DW; Dvorak AM; Weller PF
    J Infect Dis; 1985 Dec; 152(6):1317-23. PubMed ID: 3934292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brugia malayi: microfilarial polyunsaturated fatty acid composition and synthesis.
    Liu LX; Weller PF
    Exp Parasitol; 1989 Aug; 69(2):198-203. PubMed ID: 2502426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
    Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis.
    Chirkov YY; Mishra K; Chandy S; Holmes AS; Kanna R; Horowitz JD
    J Heart Valve Dis; 2006 Jan; 15(1):28-33. PubMed ID: 16480009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP; Hothersall JS; Noronha-Dutra AA
    Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D; de Nucci G; Vane JR
    Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sodium periodate on platelet functions.
    Cazenave JP; Reimers HJ; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Lab Invest; 1976 May; 34(5):471-81. PubMed ID: 178961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
    Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
    Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.